These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10688015)
1. Media hype in the medical literature: what's a doctor to do? Murphy WM J Urol; 2000 Mar; 163(3):916-8. PubMed ID: 10688015 [No Abstract] [Full Text] [Related]
2. Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice. Vrooman OP; Witjes JA Curr Opin Urol; 2010 Sep; 20(5):437-42. PubMed ID: 20657286 [TBL] [Abstract][Full Text] [Related]
3. Earlier use of aggressive therapy could prevent one-third of bladder cancer deaths. Pinkowish MD CA Cancer J Clin; 2009; 59(3):142-4. PubMed ID: 19369683 [No Abstract] [Full Text] [Related]
4. [Survey on superficial bladder tumors with members of the French Association of Urology]. Gattegno B; Ciofu C; Chopin D; Prog Urol; 2001 Nov; 11(5):1177-90. PubMed ID: 11769081 [No Abstract] [Full Text] [Related]
6. Editorial: Bladder cancer. How can we make a difference? Soloway MS J Urol; 2003 Nov; 170(5):1781-2. PubMed ID: 14532775 [No Abstract] [Full Text] [Related]
7. Re: patterns of initial transitional cell recurrence in patients after cystectomy. Zaghloul MS J Urol; 2007 Aug; 178(2):730; author reply 730. PubMed ID: 17574607 [No Abstract] [Full Text] [Related]
8. Understanding bladder cancer death: tumor biology versus physician practice. Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer. Jancke G; Damm O; Rosell J; Jahnson S Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266 [TBL] [Abstract][Full Text] [Related]
14. Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists. Clarke NS; Basu S; Prescott S; Puri R BJU Int; 2006 Apr; 97(4):716-9. PubMed ID: 16536760 [TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion as an independent predictor of recurrence and survival in node-negative bladder cancer remains to be proven. Reuter VE J Clin Oncol; 2005 Sep; 23(27):6450-1. PubMed ID: 16129842 [No Abstract] [Full Text] [Related]
18. Crossing the quality chasm in breast cancer care. Silliman RA J Clin Oncol; 2004 Sep; 22(18):3654-6. PubMed ID: 15289489 [No Abstract] [Full Text] [Related]
19. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice]. Junker K; Pilchowski R; Stöhr R; von Eggeling F; Schubert J; Hartmann A Urologe A; 2007 Sep; 46(9):1288. PubMed ID: 17593341 [No Abstract] [Full Text] [Related]
20. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Kassouf W; Spiess PE; Siefker-Radtke A; Swanson D; Grossman HB; Kamat AM; Munsell MF; Guo CC; Czerniak BA; Dinney CP Cancer; 2007 Aug; 110(4):764-9. PubMed ID: 17614317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]